Market Research Report

Global Pediatric Vaccines Market Analysis by Technology, by Vaccine Type & by End User with Regional Outlook & Forecast to 2025

Published Date :

2019-06-18

Report Pages :

320

Format :

Region Covered :

Global

Report Code :

Please Select Linenece Type

Market Overview

Pediatric vaccines are encountered to be the most successful and cost-effective tools for the improvement of public health by preventing most of the death cause diseases. This has led to ongoing increase in awareness and demand for pediatric vaccines across the globe. Moreover with the changing global environment and spread of new diseases, the R&D on the diseases for their vaccines will continue to attract the investments. But entry of new players in vaccines market is very difficult on the back of risks attached from pre-approval process to mass production. Further, the high technological advancement in the pharmaceutical industry is the key driving factors of the global pediatric vaccines market. The technologies such as synthetic vaccinology and platform manufacturing, can accelerate the process and diminish manufacturing time of new vaccines.

The GAVI business model, public-private vaccine alliance, and the morbidity issues in a region has shaped the market in terms of assessing the production, supply and prices of the vaccines. The U.S. has now achieved more than 95% reduction in morbidity rates. More than 90% of the infants are recorded to have receiving most important and recommended vaccinations by the age of 2 years. Whereas, in the African countries there still is a long way to go to achieve such morbidity rates.

Further, parental concerns and awareness regarding the vaccination is the most essential part of the complete pediatric vaccination campaign. Across the developing and under developed countries, vaccination awareness campaigns are carried out by the government, NGO’s and other healthcare agencies. Therefore, these campaigns have been the major factor for the rise in production of pediatric vaccines and growth in revenue of the pharmaceutical companies. In recent years, with the launch of new vaccines such as HPV vaccine & others has led to expansion of pediatric vaccines market. This market is majorly supplied by four companies namely, GlaxoSmithKline, Sanofi‐Pasteur, Pfizer and Merck, with a market share of 75% in 2017. The total pediatric vaccines market is expected to reach nearly USD 45,600 million by 2025, which is estimated to grow at a CAGR of USD 10.2% over the forecast period.

Pediatric Vaccine Market Segmentation

Our Global Pediatric Vaccines Market can be segmented on the following basis:

Based on Technology

  • Live, Attenuated Vaccines Market Analysis
  • Inactivated Vaccines Market Analysis
  • Toxoid/Inactive Vaccines Market Analysis
  • Conjugate/Subunit Vaccines Market Analysis

Based on Vaccine Type

  • Monovalent Vaccine Market Analysis
  • Multivalent Vaccine Market Analysis

Based on End User 

  • Hospitals
  • Pediatric Clinics
  • Academic & Research Organizations
  • Other Healthcare Facilities

Based on Geography 

  • North America (U.S. & Canada) Pediatric Vaccines Market {Market Share (%), Market Size (USD Billion)}
  • Latin America (Brazil, Mexico & Rest Of Latin America) Pediatric Vaccines Market {Market Share (%), Market Size (USD Billion)}
  • Europe (The U.K., Germany, France, Italy, Hungary, Spain, Poland, Sweden & Roe)  Pediatric Vaccines Market {Market Share (%), Market Size (USD Billion)}
  • Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest Of Asia)  Pediatric Vaccines Market {Market Share (%), Market Size (USD Billion)}
  • Middle East & Africa (GCC, South Africa, North Africa, Romea) Pediatric Vaccines Market {Market Share (%), Market Size (USD Billion)}

Market Share by Technology

Based on technology, conjugate/subunit vaccines accounted for largest market share of 31.8% in 2017 owing to the fact that they provide strong immunization to the targeted areas by the vaccine germ and benefiting with the creation of herd immunity, thus it has high adoption across the world.

As per the estimates of Centers for Disease Control and Prevention (CDC) for the period of November 2017 to February 2018, it concluded that influenza A (H3N2) virus vaccines were 36% effective including both adults and children. On the other hand, among the children between 6 months to 8 years effectiveness for flu vaccines was 59%. This reflects the efficiency of pediatric vaccines as compared to adult vaccines. Thus, for the manufacturers of the vaccines it is feasible to target those regions with high generation Z population and low morbidity rate.

Expert Analysis

UNICEF with the government, NGOs and more UN agencies are taking steps to provide immunization to children.  The lives of the children at risk equally impacts the wellbeing of their society and thus UNICEF is approaching all poorer countries and every remote locations in the world by the GAVI, the private-public vaccine alliance. The vaccine industry players such as GlaxoSmithKline, Sanofi‐Pasteur, Pfizer and Merck among others have joined hands with UNICEF for the investments and technologies to improve and develop new vaccines. Furthermore, the new vaccines are witnessed to reach children in the developing countries at much rapid pace, due to the actions of GAVI. Moreover, the prices of vaccines in these countries are significantly low as compared to developed countries i.e. in 2015 price of PCV was nearly USD 2 among the 3,200 million people demand, whereas in USA the price of PCV was nearly USD 100 among the 96 million people demand.

Data Covered in this Global Pediatric Vaccines Market Outlook

  • Pediatric vaccines market size (USD Billion) and compound annual growth rate (%), 2017-2025
  • Pediatric vaccines potential markets, major markets, opportunistic markets, growing markets (by region, countries), 2017-2018
  • Pediatric vaccines market size (USD Billion) and compound annual growth rate (%), by Technology, 2017-2025
  • Pediatric vaccines market size (USD Billion) and compound annual growth rate (%), by Vaccine Type, 2017-2025
  • Pediatric vaccines market size (USD Billion) and compound annual growth rate (%), by End User, 2017-2025
  • Pediatric vaccines immunization coverage, by region, 2013-2017
  • Ratio of vaccinated and unvaccinated children, by region, 2016-17
  • Number of new cases diagnosed of preventable chronic diseases by vaccination, 2016-17
  • New pediatric vaccines in the market and pediatric vaccines under pipeline
  • Number of new vaccine manufacturers in pediatric vaccines market, 2017-2025
  • Competitors Analysis

For a full detailed overview, send here request for market report sample.

Key Questions Answered in this research report

  • What is the total market size by 2025 and what would be the expected growth rate of market?
  • What is the total revenue per segment and region in 2016-17 and what would be the expected revenue per segment and region over the forecast period?
  • What are the key market trends?
  • What are the factors which are driving this market?
  • What are the major barriers to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities for the existing and entry level players?
  • What are the recent developments and business strategy of the key players?

Reasons to buy this market study

  • Facilitate decision-making based on strong historic and forecast data for Pediatric Vaccines Market
  • Develop strategies based on the latest regulatory framework
  • Position yourself to gain the maximum advantage of the Pediatric Vaccines market’s growth potential
  • Identify key partners and business development avenues across the globe
  • Respond to your competitors’ business structure, strategy and prospects



{ }

Global Pediatric Vaccines Market Analysis by Technology, by Vaccine Type & by End User with Regional Outlook & Forecast to 2025

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747

Table of Contents